At the centre of our transformation is a commitment to the highest standards of scientific excellence. We welcome rigorous examination and invite anyone to explore our data, methodologies, analyses, and findings. Discover more about the integrity of our scientific research

Can nicotine pouches help Europe accelerate toward a smoke-free future? Our Chief Communications Officer Dr. Moira Gilchrist & Member of the European Parliament Charlie Weimers join @spectator to discuss Sweden’s smoke-free success & the science behind it. 🎧 Listen here

What happens if smoke-free products are banned? The idea may seem logical, but the reality is these bans make it harder for adult smokers that don’t quit cigarettes and nicotine completely to switch to less harmful alternatives. Nevena explains why banning smoke-free

Nicotine … a hugely misunderstood molecule. It’s not the primary cause of smoking-related disease. It’s not carcinogenic. The biggest problem is the high levels of harmful chemicals released when tobacco is burned. But smoke-free products don’t burn tobacco. Yes,

“Why don’t you just stop selling cigarettes?” Ah, one of our most-asked questions. If we abruptly stopped the sales of cigarettes, people would simply turn to other brands or worse still, the illicit market. Nevena explains how switching adult smokers who don’t quit to

What makes a smoke-free product, smoke-free? Step 1: Recognize the problem with burning tobacco. Step 2: Develop, scientifically substantiate, and offer adult smokers a portfolio of smoke-free products that avoid burning. These products either heat tobacco, heat a vape liquid,

@CNN @drsanjaygupta @UCSF Update: CNN has updated @drsanjaygupta 's podcast to correct certain factual errors. See more here:

We appreciate @CNN's decision to update @drsanjaygupta's podcast with @UCSF's Pamela Ling to correct certain factual errors and clarify key points about ZYN and PMI's businesses. Accurate information matters—especially from the media, so the public is not misled on important

Our climate transition strategy is having an impact.  We’re on track to achieve carbon-neutrality in our direct operations by year-end 2025, with a further target of net-zero greenhouse gas emissions in our value chain by 2040.   Find out how we’re working toward a more

Informed legal-age adults deserve informed choices. Our latest survey shows that a strong majority of U.S. voters believe the FDA should distinguish between cigarettes and smoke-free alternatives. We agree. If innovation is supported by smart regulation, public health can

What are smoke-free products? How do they work? Are they really less harmful than cigarettes? We understand why you’re asking—and we’re eager to share our answers. From burning to regulation, our VP Public Affairs, Nevena Crljenko, tackles the big questions. Let’s open the

We are on track to achieve carbon neutrality in our direct operations by the end of 2025. Our Climate Transition Plan outlines how we will continue to decarbonize across our value chain and the importance of forging deep partnerships, from suppliers to logistics and

Two weeks ago, we formally requested @CNN to correct significant factual errors and misleading statements about nicotine pouches on @drsanjaygupta’s podcast with @UCSF’s Pamela Ling. We're still waiting. So, we sent them another request.

Pleased to launch our latest Climate Transition Plan—mapping our ongoing commitment to delivering a low-carbon future. Building on our 2021 plan, it aligns with the latest science, regulatory frameworks, and stakeholder expectations, while restating our goal of achieving

What is snus? A simple question, with a simple answer. Most commonly found in countries where smoking rates have declined significantly, oral smokeless products such as snus have played a key part in their success. While it does contain nicotine, which is addictive, snus

Want to hear more about our quarterly earnings? Our CFO, Emmanuel Babeau, gives you the lowdown ⬇️

Earnings season is heating up🔥 @InsidePMI CEO Jacek Olczak offers an exclusive look at how the company behind brands like Marlboro and Zyn performed in Q3: https://t.co/1ueqCC5pmK

Our Q3 results are out. Here’s the impact in numbers: 🔘 41% of our total global net revenues came from our smoke-free business* 🔘 100 markets where our smoke-free products are available** But this isn’t just about numbers. It’s about the impact we’re creating together

Innovation needs a regulatory framework that keeps up. Strong majorities of U.S. voters have expressed support for FDA reform. We’re calling for a system that recognizes the difference between combustible cigarettes and scientifically substantiated smoke-free alternatives.

Too often, nicotine is misunderstood—and misrepresented. Many still wrongly believe it’s the main cause of smoking-related diseases. But the science tells a different story. Moira Gilchrist, our Chief Communications Officer, explains in her latest video that nicotine, although

One in five adults who smoke don’t have access to smoke-free products. Progress happens when people have access to better alternatives, and the freedom to choose. Explore the numbers and see the impact for yourself. #ProgressMatters